News & Updates
Filter by Specialty:
Remote ischaemic conditioning improves neurologic function in acute stroke
Treatment with remote ischaemic conditioning in adults with acute moderate ischaemic stroke appears to increase the chances of achieving excellent neurologic function at 90 days as compared with usual care, as shown in the results of an open-label, blinded-endpoint, randomized clinical trial.
Remote ischaemic conditioning improves neurologic function in acute stroke
22 Aug 2022
Subgroup analyses boost masupirdine potential for AD
Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).
Subgroup analyses boost masupirdine potential for AD
15 Aug 2022
Depression, anxiety, sleep troubles common in primary Sjögren’s syndrome
Patients with primary Sjögren’s syndrome (pSS) show high levels of depression, anxiety, and sleep disturbances, reports a recent study. Cognitive impairments are also prevalent in this patient population.